NM_001348946.2:c.2686-898A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001348946.2(ABCB1):​c.2686-898A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.483 in 812,910 control chromosomes in the GnomAD database, including 98,811 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 21401 hom., cov: 32)
Exomes 𝑓: 0.47 ( 77410 hom. )

Consequence

ABCB1
NM_001348946.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.11

Publications

11 publications found
Variant links:
Genes affected
ABCB1 (HGNC:40): (ATP binding cassette subfamily B member 1) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]
HNRNPA1P9 (HGNC:39127): (heterogeneous nuclear ribonucleoprotein A1 pseudogene 9)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.603 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCB1NM_001348946.2 linkc.2686-898A>G intron_variant Intron 21 of 27 ENST00000622132.5 NP_001335875.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCB1ENST00000622132.5 linkc.2686-898A>G intron_variant Intron 21 of 27 1 NM_001348946.2 ENSP00000478255.1

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
79483
AN:
151872
Hom.:
21365
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.609
Gnomad AMI
AF:
0.600
Gnomad AMR
AF:
0.495
Gnomad ASJ
AF:
0.588
Gnomad EAS
AF:
0.221
Gnomad SAS
AF:
0.322
Gnomad FIN
AF:
0.440
Gnomad MID
AF:
0.509
Gnomad NFE
AF:
0.523
Gnomad OTH
AF:
0.545
GnomAD4 exome
AF:
0.473
AC:
312911
AN:
660920
Hom.:
77410
Cov.:
7
AF XY:
0.467
AC XY:
167326
AN XY:
358082
show subpopulations
African (AFR)
AF:
0.613
AC:
11351
AN:
18514
American (AMR)
AF:
0.422
AC:
18373
AN:
43492
Ashkenazi Jewish (ASJ)
AF:
0.592
AC:
12544
AN:
21186
East Asian (EAS)
AF:
0.216
AC:
7804
AN:
36156
South Asian (SAS)
AF:
0.322
AC:
22746
AN:
70718
European-Finnish (FIN)
AF:
0.445
AC:
16612
AN:
37322
Middle Eastern (MID)
AF:
0.504
AC:
1343
AN:
2664
European-Non Finnish (NFE)
AF:
0.517
AC:
205113
AN:
396632
Other (OTH)
AF:
0.497
AC:
17025
AN:
34236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
8637
17274
25910
34547
43184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1818
3636
5454
7272
9090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.524
AC:
79571
AN:
151990
Hom.:
21401
Cov.:
32
AF XY:
0.515
AC XY:
38245
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.609
AC:
25252
AN:
41478
American (AMR)
AF:
0.495
AC:
7559
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.588
AC:
2042
AN:
3472
East Asian (EAS)
AF:
0.221
AC:
1143
AN:
5174
South Asian (SAS)
AF:
0.323
AC:
1554
AN:
4810
European-Finnish (FIN)
AF:
0.440
AC:
4639
AN:
10532
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.523
AC:
35540
AN:
67948
Other (OTH)
AF:
0.541
AC:
1144
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1908
3816
5724
7632
9540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
680
1360
2040
2720
3400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.516
Hom.:
2965
Bravo
AF:
0.531
Asia WGS
AF:
0.318
AC:
1111
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
1.1
DANN
Benign
0.34
PhyloP100
3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4148743; hg19: chr7-87151090; COSMIC: COSV55959175; COSMIC: COSV55959175; API